Zai Lab Q3 EPS $(0.71) Beats $(0.95) Estimate, Sales $69.23M Miss $74.85M Estimate
Portfolio Pulse from bharat@benzinga.com
Zai Lab (NASDAQ:ZLAB) reported Q3 losses of $(0.71) per share, beating the analyst consensus estimate of $(0.95) by 25.26 percent. However, the company's quarterly sales of $69.23 million missed the analyst consensus estimate of $74.85 million by 7.51 percent.
November 07, 2023 | 9:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zai Lab's Q3 earnings beat estimates but sales missed, which could lead to mixed market reactions.
Zai Lab's earnings beat could boost investor confidence, but the sales miss might offset this positive sentiment. The net impact on the stock price could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100